HEADER HYDROLASE/HYDROLASE INHIBITOR 30-MAR-15 4Z2G TITLE SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH MACROLIDE INHIBITOR 26 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITINASE B; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.14; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SERRATIA MARCESCENS; SOURCE 3 ORGANISM_TAXID: 615; SOURCE 4 GENE: CHIB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH5ALPHA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 668369; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTRCHISB KEYWDS CHITINASE, INHIBITOR, MACROLIDE, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.MAITA,A.SUGAWARA,T.SUNAZUKA REVDAT 5 30-OCT-24 4Z2G 1 REMARK REVDAT 4 08-NOV-23 4Z2G 1 REMARK REVDAT 3 05-FEB-20 4Z2G 1 SOURCE KEYWDS JRNL REMARK REVDAT 2 08-JUL-15 4Z2G 1 JRNL REVDAT 1 01-JUL-15 4Z2G 0 JRNL AUTH A.SUGAWARA,N.MAITA,H.GOUDA,T.YAMAMOTO,T.HIROSE,S.KIMURA, JRNL AUTH 2 Y.SAITO,H.NAKANO,T.KASAI,H.NAKANO,K.SHIOMI,S.HIRONO, JRNL AUTH 3 T.WATANABE,H.TANIGUCHI,S.OMURA,T.SUNAZUKA JRNL TITL CREATION OF CUSTOMIZED BIOACTIVITY WITHIN A 14-MEMBERED JRNL TITL 2 MACROLIDE SCAFFOLD: DESIGN, SYNTHESIS, AND BIOLOGICAL JRNL TITL 3 EVALUATION USING A FAMILY-18 CHITINASE JRNL REF J.MED.CHEM. V. 58 4984 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26030312 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00175 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 27648 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1479 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1992 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.3340 REMARK 3 BIN FREE R VALUE SET COUNT : 101 REMARK 3 BIN FREE R VALUE : 0.3740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3913 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.47000 REMARK 3 B22 (A**2) : 1.47000 REMARK 3 B33 (A**2) : -2.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.367 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.300 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.226 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.575 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4127 ; 0.015 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3784 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5634 ; 1.590 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8669 ; 0.840 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 497 ; 6.410 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 194 ;36.189 ;24.124 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 601 ;15.357 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;20.402 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 599 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4745 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1019 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1991 ; 4.487 ; 4.822 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1990 ; 4.483 ; 4.819 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2487 ; 6.654 ; 7.220 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2488 ; 6.655 ; 7.222 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2136 ; 4.116 ; 5.110 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2137 ; 4.116 ; 5.111 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3148 ; 6.333 ; 7.577 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4871 ; 8.963 ;39.895 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4863 ; 8.959 ;39.892 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4Z2G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000207801. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 -7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9800 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29200 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 11.80 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 11.10 REMARK 200 R MERGE FOR SHELL (I) : 0.62000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3WD0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES-NA PH7.0, 0.8M AMMONIUM REMARK 280 SULFATE, 5% (V/V) GLYCEROL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 96.92000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 48.49000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 48.49000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 145.38000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 48.49000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 48.49000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.46000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 48.49000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.49000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 145.38000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 48.49000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.49000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 48.46000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 96.92000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 625 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 667 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 683 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -3 REMARK 465 PRO A -2 REMARK 465 SER A -1 REMARK 465 SER A 0 REMARK 465 ARG A 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 2 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 650 O HOH A 663 2.16 REMARK 500 O HOH A 636 O HOH A 684 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 26 -7.97 -56.75 REMARK 500 PRO A 64 -35.94 -39.85 REMARK 500 ALA A 65 48.28 -99.46 REMARK 500 ARG A 174 30.90 -99.14 REMARK 500 ALA A 228 41.04 -159.27 REMARK 500 ASN A 303 52.82 -144.90 REMARK 500 LYS A 335 31.78 72.60 REMARK 500 GLN A 347 -71.22 -44.70 REMARK 500 TYR A 353 -19.94 -143.34 REMARK 500 ASN A 423 -78.63 -83.76 REMARK 500 ALA A 424 117.12 -25.40 REMARK 500 ASP A 429 29.19 -143.02 REMARK 500 TYR A 470 124.07 -170.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M6V A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M6V A 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3WD0 RELATED DB: PDB REMARK 900 3WD0 CONTAINS THE SAME PROTEIN. REMARK 900 RELATED ID: 4Z2H RELATED DB: PDB REMARK 900 RELATED ID: 4Z2I RELATED DB: PDB REMARK 900 RELATED ID: 4Z2J RELATED DB: PDB REMARK 900 RELATED ID: 4Z2K RELATED DB: PDB REMARK 900 RELATED ID: 4Z2L RELATED DB: PDB DBREF 4Z2G A 2 499 UNP P11797 CHIB_SERMA 2 499 SEQADV 4Z2G ASP A -3 UNP P11797 EXPRESSION TAG SEQADV 4Z2G PRO A -2 UNP P11797 EXPRESSION TAG SEQADV 4Z2G SER A -1 UNP P11797 EXPRESSION TAG SEQADV 4Z2G SER A 0 UNP P11797 EXPRESSION TAG SEQADV 4Z2G ARG A 1 UNP P11797 EXPRESSION TAG SEQRES 1 A 503 ASP PRO SER SER ARG SER THR ARG LYS ALA VAL ILE GLY SEQRES 2 A 503 TYR TYR PHE ILE PRO THR ASN GLN ILE ASN ASN TYR THR SEQRES 3 A 503 GLU THR ASP THR SER VAL VAL PRO PHE PRO VAL SER ASN SEQRES 4 A 503 ILE THR PRO ALA LYS ALA LYS GLN LEU THR HIS ILE ASN SEQRES 5 A 503 PHE SER PHE LEU ASP ILE ASN SER ASN LEU GLU CYS ALA SEQRES 6 A 503 TRP ASP PRO ALA THR ASN ASP ALA LYS ALA ARG ASP VAL SEQRES 7 A 503 VAL ASN ARG LEU THR ALA LEU LYS ALA HIS ASN PRO SER SEQRES 8 A 503 LEU ARG ILE MET PHE SER ILE GLY GLY TRP TYR TYR SER SEQRES 9 A 503 ASN ASP LEU GLY VAL SER HIS ALA ASN TYR VAL ASN ALA SEQRES 10 A 503 VAL LYS THR PRO ALA ALA ARG THR LYS PHE ALA GLN SER SEQRES 11 A 503 CYS VAL ARG ILE MET LYS ASP TYR GLY PHE ASP GLY VAL SEQRES 12 A 503 ASP ILE ASP TRP GLU TYR PRO GLN ALA ALA GLU VAL ASP SEQRES 13 A 503 GLY PHE ILE ALA ALA LEU GLN GLU ILE ARG THR LEU LEU SEQRES 14 A 503 ASN GLN GLN THR ILE ALA ASP GLY ARG GLN ALA LEU PRO SEQRES 15 A 503 TYR GLN LEU THR ILE ALA GLY ALA GLY GLY ALA PHE PHE SEQRES 16 A 503 LEU SER ARG TYR TYR SER LYS LEU ALA GLN ILE VAL ALA SEQRES 17 A 503 PRO LEU ASP TYR ILE ASN LEU MET THR TYR ASP LEU ALA SEQRES 18 A 503 GLY PRO TRP GLU LYS ILE THR ASN HIS GLN ALA ALA LEU SEQRES 19 A 503 PHE GLY ASP ALA ALA GLY PRO THR PHE TYR ASN ALA LEU SEQRES 20 A 503 ARG GLU ALA ASN LEU GLY TRP SER TRP GLU GLU LEU THR SEQRES 21 A 503 ARG ALA PHE PRO SER PRO PHE SER LEU THR VAL ASP ALA SEQRES 22 A 503 ALA VAL GLN GLN HIS LEU MET MET GLU GLY VAL PRO SER SEQRES 23 A 503 ALA LYS ILE VAL MET GLY VAL PRO PHE TYR GLY ARG ALA SEQRES 24 A 503 PHE LYS GLY VAL SER GLY GLY ASN GLY GLY GLN TYR SER SEQRES 25 A 503 SER HIS SER THR PRO GLY GLU ASP PRO TYR PRO ASN ALA SEQRES 26 A 503 ASP TYR TRP LEU VAL GLY CYS ASP GLU CYS VAL ARG ASP SEQRES 27 A 503 LYS ASP PRO ARG ILE ALA SER TYR ARG GLN LEU GLU GLN SEQRES 28 A 503 MET LEU GLN GLY ASN TYR GLY TYR GLN ARG LEU TRP ASN SEQRES 29 A 503 ASP LYS THR LYS THR PRO TYR LEU TYR HIS ALA GLN ASN SEQRES 30 A 503 GLY LEU PHE VAL THR TYR ASP ASP ALA GLU SER PHE LYS SEQRES 31 A 503 TYR LYS ALA LYS TYR ILE LYS GLN GLN GLN LEU GLY GLY SEQRES 32 A 503 VAL MET PHE TRP HIS LEU GLY GLN ASP ASN ARG ASN GLY SEQRES 33 A 503 ASP LEU LEU ALA ALA LEU ASP ARG TYR PHE ASN ALA ALA SEQRES 34 A 503 ASP TYR ASP ASP SER GLN LEU ASP MET GLY THR GLY LEU SEQRES 35 A 503 ARG TYR THR GLY VAL GLY PRO GLY ASN LEU PRO ILE MET SEQRES 36 A 503 THR ALA PRO ALA TYR VAL PRO GLY THR THR TYR ALA GLN SEQRES 37 A 503 GLY ALA LEU VAL SER TYR GLN GLY TYR VAL TRP GLN THR SEQRES 38 A 503 LYS TRP GLY TYR ILE THR SER ALA PRO GLY SER ASP SER SEQRES 39 A 503 ALA TRP LEU LYS VAL GLY ARG LEU ALA HET M6V A 501 50 HET M6V A 502 50 HETNAM M6V (1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,17S)-3-ETHYL-2,10- HETNAM 2 M6V DIHYDROXY-2,6,8,10,12,15,15,17-OCTAMETHYL-5-OXO-9- HETNAM 3 M6V (PROP-2-YN-1-YLOXY)-4,14,16- HETNAM 4 M6V TRIOXABICYCLO[11.3.1]HEPTADEC-7-YL {4-[N'- HETNAM 5 M6V (METHYLCARBAMOYL)CARBAMIMIDAMIDO]BUTYL}CARBAMATE FORMUL 2 M6V 2(C35 H61 N5 O10) FORMUL 4 HOH *87(H2 O) HELIX 1 AA1 PRO A 14 ASN A 20 1 7 HELIX 2 AA2 PRO A 32 ILE A 36 5 5 HELIX 3 AA3 THR A 37 LEU A 44 1 8 HELIX 4 AA4 ASN A 67 ALA A 80 1 14 HELIX 5 AA5 LEU A 81 ASN A 85 5 5 HELIX 6 AA6 GLY A 96 ASN A 101 1 6 HELIX 7 AA7 SER A 106 VAL A 114 1 9 HELIX 8 AA8 THR A 116 GLY A 135 1 20 HELIX 9 AA9 GLN A 147 ASP A 172 1 26 HELIX 10 AB1 GLY A 188 SER A 193 1 6 HELIX 11 AB2 ARG A 194 SER A 197 5 4 HELIX 12 AB3 LYS A 198 ALA A 204 1 7 HELIX 13 AB4 ASN A 241 ALA A 246 5 6 HELIX 14 AB5 SER A 251 PHE A 259 1 9 HELIX 15 AB6 THR A 266 MET A 276 1 11 HELIX 16 AB7 PRO A 281 ALA A 283 5 3 HELIX 17 AB8 CYS A 328 ASP A 334 1 7 HELIX 18 AB9 TYR A 342 GLY A 351 1 10 HELIX 19 AC1 GLU A 383 GLN A 395 1 13 HELIX 20 AC2 HIS A 404 ASP A 408 5 5 HELIX 21 AC3 GLY A 412 ASN A 423 1 12 SHEET 1 AA110 CYS A 60 ALA A 61 0 SHEET 2 AA110 HIS A 46 ILE A 54 -1 N ASP A 53 O ALA A 61 SHEET 3 AA110 ARG A 89 GLY A 95 1 O SER A 93 N PHE A 49 SHEET 4 AA110 GLY A 138 ASP A 142 1 O ASP A 142 N ILE A 94 SHEET 5 AA110 GLN A 180 ALA A 186 1 O GLN A 180 N VAL A 139 SHEET 6 AA110 TYR A 208 MET A 212 1 O ASN A 210 N ILE A 183 SHEET 7 AA110 ILE A 285 PRO A 290 1 O VAL A 286 N LEU A 211 SHEET 8 AA110 GLY A 399 TRP A 403 1 O MET A 401 N MET A 287 SHEET 9 AA110 ALA A 6 PHE A 12 1 N ILE A 8 O VAL A 400 SHEET 10 AA110 HIS A 46 ILE A 54 1 O SER A 50 N TYR A 11 SHEET 1 AA2 5 ILE A 339 SER A 341 0 SHEET 2 AA2 5 TYR A 292 LYS A 297 -1 N GLY A 293 O ALA A 340 SHEET 3 AA2 5 LEU A 375 TYR A 379 -1 O PHE A 376 N PHE A 296 SHEET 4 AA2 5 THR A 365 HIS A 370 -1 N HIS A 370 O LEU A 375 SHEET 5 AA2 5 TYR A 355 ASN A 360 -1 N LEU A 358 O TYR A 367 SHEET 1 AA3 3 LEU A 467 TYR A 470 0 SHEET 2 AA3 3 TYR A 473 THR A 477 -1 O TRP A 475 N VAL A 468 SHEET 3 AA3 3 TRP A 492 ARG A 497 -1 O GLY A 496 N VAL A 474 SSBOND 1 CYS A 328 CYS A 331 1555 1555 2.00 CISPEP 1 SER A 50 PHE A 51 0 5.30 CISPEP 2 GLU A 144 TYR A 145 0 0.80 CISPEP 3 SER A 261 PRO A 262 0 6.68 CISPEP 4 ASP A 316 PRO A 317 0 1.14 CISPEP 5 TRP A 403 HIS A 404 0 -10.57 CISPEP 6 GLY A 480 TYR A 481 0 -1.39 SITE 1 AC1 12 TYR A 10 PHE A 12 TYR A 98 ASP A 142 SITE 2 AC1 12 GLU A 144 MET A 212 TYR A 214 ASP A 215 SITE 3 AC1 12 TYR A 292 LYS A 335 TRP A 403 HOH A 617 SITE 1 AC2 11 TRP A 97 ASP A 102 ILE A 170 PHE A 190 SITE 2 AC2 11 PHE A 191 ASP A 215 TRP A 220 GLU A 221 SITE 3 AC2 11 PHE A 239 TYR A 481 THR A 483 CRYST1 96.980 96.980 193.840 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010311 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010311 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005159 0.00000